Stockreport

AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF Tagrisso is indicated for patients with exon 19 deletions or exon 21 (L858R) mutations. Tagrisso is AstraZeneca's top-selling cancer drug, and in the second quarter o [Read more]